Discovery ofLenacapavir: First-in-Class Twice-YearlyCapsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis
Eda Canales(Gilead Sciences (United States)), John O. Link(Gilead Sciences (United States)), Eric Hu(Gilead Sciences (United States)), Jason K. Perry(Pulmatrix (United States)), Jim Zheng(Gilead Sciences (United States)), Randall L. Halcomb(Gilead Sciences (United States)), George Stepan(Gilead Sciences (United States)), Latesh Lad, Eric A. Singer(Rutgers Cancer Institute of New Jersey), Armando G. Villaseñor(Gilead Sciences (United States)), Kelly Wang(Gilead Sciences (United States)), Rujuta A. Bam(Gilead Sciences (United States)), Bill J. Smith(Gilead Sciences (United States)), Raju Subramanian(Gilead Sciences (United States)), Ryan Ferrao(Gilead Sciences (United States)), John R. Somoza(Gilead Sciences (United States)), Dorothea Sauer(University Clinic for Nephrology and Hypertension, Diabetology and Endocrinology), Jennifer Zhang(Bristol-Myers Squibb (Germany)), Tomáš Cihlář(Gilead Sciences (United States)), Michael Graupe(Gilead Sciences (United States)), Chien‐Hung Chou(Gilead Sciences (United States)), Roman Sakowicz(Gilead Sciences (United States)), Sheila Clancy(Gilead Sciences (United States)), Derek Hansen(Gilead Sciences (United States)), S. Swaminathan(Gilead Sciences (United States)), Helen Yu(Hospital for Sick Children), Carina Cannizzaro, Roland D. Saito(Gilead Sciences (United States)), Bing Shi(Gilead Sciences (United States)), Gavin Carr(MACOM (United States)), Giuseppe A. Papalia(Gilead Sciences (United States)), Gerry Rhodes(Gilead Sciences (United States)), William Rowe(Gilead Sciences (United States)), Stephen R. Yant(Gilead Sciences (United States)), Gediminas Brizgys(Gilead Sciences (United States)), Winston C. Tse(Gilead Sciences (United States)), Philip Morganelli(Gilead Sciences (United States)), Andrew Mulato(Gilead Sciences (United States)), Scott E. Lazerwith(University of California, San Francisco), Qi Liu(Tongji University), Jiayao Li(Analytical Biosciences (China)), Qiaoyin Wu(Gilead Sciences (United States)), Bing Lu(Gilead Sciences (United States)), Manoj C. Desai(Gilead Sciences (United States)), Scott D. Schroeder(Gilead Sciences (United States)), Luong Tsai(Gilead Sciences (United States)), Judy Mwangi(Gilead Sciences (United States))
Cited by 11
Related Papers
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
|Nature|2017|1.2k
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
|Cell Reports|2020|541
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
|Drug Metabolism and Disposition|2002|346